Fish oil and protein shake may fight chemo muscle loss
NCT ID NCT01871350
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a daily drink containing milk protein, carbohydrates, and fish oil could help cancer patients on chemotherapy maintain muscle and gut function. Researchers enrolled 31 people with cancer and compared them to healthy controls. The goal was to see if the supplement could reduce weight loss and muscle wasting, common side effects of chemo.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- milk protein, carbohydrate, and fish oil supplement
- What this could lead to
- If it works, this could point toward a simple nutritional drink that helps cancer patients keep muscle and strength during chemotherapy.
- What could go wrong
- This is a small, early-stage study with only 31 people, so results may not apply to everyone. Past studies on fish oil for weight loss in cancer have been inconclusive.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
31 people
The number who actually took part.
- Started
-
Apr 2013
- Finished
-
Nov 2015
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria cancer subjects: * Diagnosed with cancer * Scheduled for chemotherapy or chemoradiotherapy * Ability to sign informed consent * Age 18y and older * Ability to lie in supine position for 7 hours Inclusion criteria healthy subjects: * Healthy male or female according to the investigator's or appointed staff's judgment * Age 18 years or older * No diagnosis of cancer Exclusion Criteria * Presence of fever within the last 3 days * BMI \> 38 kg/m2 (healthy controls only) * Untreated metabolic diseases including hepatic or renal disorder * Presence of acute illness or metabolically unstable chronic illness * Use of protein or amino acid containing nutritional supplements within 5 days of first test day * Known hypersensitivity to fish and/or shellfish, Swanson EFAs Super EPA Fish oil or any of its ingredients, Swanson EFAs Certified Organic Extra Virgin Olive oil or any of its ingredients, Smartfish Nutrifriend or any of its ingredients (Cancer subjects only) * Use of supplements containing EPA+DHA 3 months prior to the first test day * Any other condition according to the PI or nurse that would interfere with the study or safety of the patient * Failure to give informed consent * (Possible) pregnancy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Texas A&M University
College Station, Texas, 77843, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can colorectal surgery patients go home in two days?
- Can a personal navigator help young cancer patients through treatment?
- Can a smartwatch predict which cancer patients return to hospital?
- Two-Drug combo aims to stall advanced breast cancer
- Blood thinner flush could boost tumor biopsy success
- Could a frailty score predict which older cancer patients survive intensive care?